Skip to main content

lacosamide (Vimpat®)


Status: In progress

Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in children from 2 years of age to ≤  4 years of age with epilepsy.

Medicine details

Medicine name lacosamide (Vimpat®)
Formulation 10 mg/ml syrup; 10 mg/ml solution for infusion; 50 mg, 100 mg, 150 mg, 200 mg film-coated tablets
Reference number 4698

As above

Company UCB Pharma Ltd
BNF chapter Central nervous system
Submission type Licence extension for paediatric use
Status In progress
AWMSG meeting date 14/09/2022
Date of issue TBC
Follow AWTTC: